Template Quality Control for PCR and qPCR: Assessing DNA and RNA Integrity

Template quality control is the systematic evaluation of DNA or RNA integrity, purity, and concentration prior to PCR or qPCR amplification. This process is essential because degraded, contaminated, or improperly quantified templates produce unreliable amplification results, including false negatives, skewed quantification, and irreproducible data. Template quality control is useful whenever you need to confirm that your starting material can support efficient and specific amplification, particularly when working with archived samples, limited quantities, or when comparing results across multiple samples. The methods described here—gel electrophoresis, spectrophotometry, fluorometry, and RNA integrity assessment—provide complementary information about template condition and should be selected based on your sample type, downstream application, and available instrumentation.

At a Glance

Scientific Principle: Why Template Quality Matters

PCR and qPCR depend on the ability of DNA polymerase to extend primers along an intact template strand. When templates are degraded, fragmented, or contaminated with inhibitors, the amplification process is compromised in several ways. Degraded DNA templates produce shorter amplicons but may still amplify if the target region remains intact; however, quantification becomes unreliable because the number of amplifiable copies no longer reflects the original template concentration. For RNA templates used in RT-qPCR, degradation is even more critical because reverse transcriptase requires intact RNA to generate full-length cDNA. Degraded RNA leads to underrepresentation of 5' transcript regions and systematic bias in gene expression measurements.

Contaminants interfere with PCR through multiple mechanisms. Proteins and polysaccharides can bind DNA polymerase or sequester magnesium ions, reducing amplification efficiency. Phenol and ethanol residues from extraction protocols denature enzymes or inhibit their activity. Guanidine salts, common in RNA extraction buffers, are potent reverse transcriptase inhibitors even at low concentrations. These inhibitors produce delayed Ct values, reduced endpoint fluorescence, and altered melt curves, all of which compromise data quality.

The MIQE (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) guidelines emphasize that RNA integrity should be reported in qPCR studies. A systematic evaluation of qPCR reporting practices found that RNA integrity was reported in only 7–10% of studies, and assessment methods or instruments used for integrity evaluation were specified in just 14–16% [1]. This reporting gap undermines reproducibility and makes it difficult to evaluate whether observed expression differences are biologically meaningful or artifacts of template degradation.

Materials and Instrumentation Choices

Spectrophotometry

Spectrophotometric analysis using instruments such as NanoDrop or standard UV spectrophotometers provides rapid assessment of nucleic acid concentration and purity. The method measures absorbance at 260 nm (nucleic acids), 280 nm (proteins), and 230 nm (phenol, guanidine, carbohydrates). Key ratios include:

• A260/A280: For pure DNA, this ratio should be approximately 1.8; for pure RNA, approximately 2.0. Lower values indicate protein or phenol contamination.
• A260/A230: Values above 1.8 indicate minimal contamination with phenol, guanidine, or carbohydrates. Lower values suggest residual extraction reagents.

Spectrophotometry cannot distinguish between intact and degraded nucleic acids, nor can it differentiate DNA from RNA in mixed samples. It also overestimates concentration in the presence of contaminants that absorb at 260 nm. For these reasons, spectrophotometry should be used as a screening tool rather than a definitive quality assessment.

Fluorometry

Fluorometric methods using dyes that specifically bind double-stranded DNA (e.g., PicoGreen, Qubit dsDNA assays) or RNA (e.g., RiboGreen, Qubit RNA assays) provide more accurate quantification than spectrophotometry. These dyes are selective for their target nucleic acid and do not measure contaminants. Fluorometry is particularly valuable when:

• Working with low-concentration samples (<10 ng/µL)
• Quantifying DNA in the presence of RNA (or vice versa)
• Preparing standard curves for absolute qPCR quantification
• Confirming template concentration before expensive or time-sensitive experiments

Gel Electrophoresis

Agarose gel electrophoresis provides visual assessment of nucleic acid integrity. For DNA, intact genomic DNA appears as a high-molecular-weight band with minimal smearing toward lower molecular weights. Degraded DNA shows a smear extending from high to low molecular weights, with loss of the distinct high-molecular-weight band. For RNA, intact total RNA shows two distinct ribosomal RNA bands (28S and 18S in eukaryotic samples, 16S and 23S in prokaryotic samples) with the 28S band approximately twice as intense as the 18S band. Degraded RNA appears as a smear with loss of distinct ribosomal bands and accumulation of low-molecular-weight fragments.

Gel electrophoresis is semi-quantitative and requires 50–200 ng of nucleic acid for visualization with ethidium bromide or SYBR Safe staining. It is not suitable for precise quantification but provides immediate visual confirmation of integrity.

Microfluidic Electrophoresis

Instruments such as the Agilent Bioanalyzer or TapeStation use microfluidic chips to separate nucleic acid fragments by size with high resolution. These systems provide:

• RNA Integrity Number (RIN): An algorithm-based score from 1 (completely degraded) to 10 (fully intact) that considers the entire electrophoretic trace, including ribosomal RNA ratios and the presence of degradation products.
• RNA Quality Indicator (RQI): Similar to RIN, used with the QIAxcel system.
• DV200: The percentage of RNA fragments longer than 200 nucleotides, useful for degraded samples such as formalin-fixed, paraffin-embedded (FFPE) tissue.

For most RT-qPCR applications, RIN values above 7 indicate acceptable RNA integrity. However, some studies have shown that even samples with RIN values as low as 5 can produce reliable results for certain targets, particularly when amplicons are short (<150 bp). The choice of RIN threshold should be validated for your specific experimental system.

Selection Criteria

The choice of quality assessment method depends on sample type, available equipment, and experimental requirements:

Controls for Template Quality Assessment

Proper controls are essential for interpreting template quality data and distinguishing sample degradation from procedural artifacts.

Positive Control

A known intact nucleic acid sample processed in parallel with test samples provides a reference for expected quality metrics. For RNA, this could be commercially available universal reference RNA or RNA extracted from a well-characterized cell line. The positive control should be stored in single-use aliquots to avoid freeze-thaw degradation.

Negative Control

Nuclease-free water processed through all quality assessment steps serves as a negative control. This control detects contamination of reagents or instruments. For spectrophotometry, the negative control should produce A260 values at or below the instrument's detection limit.

Extraction Blank

An extraction blank (all reagents processed without sample) identifies contamination introduced during nucleic acid extraction. This control is particularly important when assessing RNA integrity, as RNases from contaminated reagents can degrade samples.

No Template Control (NTC) for PCR

While not a template quality control per se, the NTC is essential for interpreting amplification results. The NTC contains all PCR reagents except template and should produce no amplification. Amplification in the NTC indicates reagent contamination or primer-dimer formation. For detailed guidance on NTC setup and interpretation, see the related article on No Template Control (NTC) in qPCR: Setup, Interpretation, and Troubleshooting.

Conceptual Workflow for Template Quality Control

The following workflow outlines a systematic approach to template quality assessment. Specific steps may vary based on sample type and available instrumentation.

Step 1: Initial Quantification and Purity Screening

Begin with spectrophotometric analysis to determine concentration and purity ratios. Record A260, A280, and A230 values. If A260/A280 or A260/A230 ratios fall outside acceptable ranges, consider whether purification is necessary before proceeding. Note that spectrophotometry may overestimate concentration in contaminated samples; therefore, do not rely solely on these values for downstream calculations.

Step 2: Integrity Assessment

For DNA templates, run 100–200 ng on a 0.8–1% agarose gel alongside a molecular weight marker. Assess the presence of a high-molecular-weight band and the extent of smearing. For RNA templates, use microfluidic electrophoresis to obtain RIN values, or run 200–500 ng on a denaturing agarose gel to visualize ribosomal RNA bands.

Step 3: Confirmatory Quantification (Optional but Recommended)

For critical applications such as absolute qPCR quantification or when working with limited samples, confirm concentration using fluorometry. Compare fluorometric values with spectrophotometric estimates; large discrepancies suggest contaminant interference.

Step 4: Documentation and Decision

Record all quality metrics in a laboratory notebook or electronic system. Establish acceptance criteria based on your experimental requirements and previous validation data. Samples that fail quality thresholds should be re-extracted, purified, or excluded from analysis.

Step 5: Pre-PCR Dilution and Storage

Dilute templates to a working concentration appropriate for your PCR or qPCR assay (typically 1–50 ng/µL for genomic DNA, 10–100 ng/µL for cDNA). Store diluted templates in low-binding tubes at 4°C for short-term use or at -20°C for longer storage. Avoid repeated freeze-thaw cycles.

Quality Checks During Template Preparation

Several quality checks should be performed during template preparation to ensure consistent results.

Homogeneity Assessment

When preparing multiple samples, verify that template concentrations are consistent across replicates. Large concentration differences can introduce systematic bias, particularly in comparative qPCR experiments where equal template input is assumed.

Inhibitor Detection

Inhibitors can be detected by spiking a known amount of control template into a sample aliquot and comparing amplification efficiency to the control alone. A significant delay in Ct values (>1 cycle) indicates inhibition. Alternatively, serial dilutions of the template can reveal inhibition if Ct values do not decrease proportionally with dilution.

Genomic DNA Contamination in RNA Samples

For RNA samples, genomic DNA contamination can be assessed by performing a no-reverse-transcriptase control (NRT) in RT-qPCR. The NRT contains all RT-qPCR reagents except reverse transcriptase. Amplification in the NRT indicates genomic DNA carryover. For detailed guidance on NRT controls, see the related article on Controls in qPCR: No Template Control, No Reverse Transcriptase Control, and Positive Control.

Result Interpretation

Interpreting Spectrophotometric Data

Interpreting Gel Electrophoresis Results

Intact genomic DNA: A single high-molecular-weight band (>10 kb) with minimal smearing. No distinct low-molecular-weight bands.

Partially degraded genomic DNA: A high-molecular-weight band with visible smearing extending to lower molecular weights. The smear may be more pronounced in samples that have undergone multiple freeze-thaw cycles.

Severely degraded genomic DNA: No distinct high-molecular-weight band; diffuse smear from high to low molecular weights. Such samples are unsuitable for PCR targeting long amplicons (>1 kb) but may still amplify short targets (<300 bp).

Intact RNA: Two distinct ribosomal RNA bands (28S and 18S in eukaryotes) with the 28S band approximately twice as intense as the 18S band. Minimal smearing between bands.

Partially degraded RNA: Ribosomal bands are visible but less distinct, with increased smearing between bands and below the 18S band.

Severely degraded RNA: No distinct ribosomal bands; diffuse smear from high to low molecular weights. Such samples are unsuitable for most RT-qPCR applications.

Interpreting RIN Values

Note that RIN values are algorithm-based and may not perfectly correlate with functional integrity for all sample types. For FFPE samples, DV200 is often more informative than RIN.

Troubleshooting Common Template Quality Issues

Limitations of Template Quality Assessment

Method-Specific Limitations

Spectrophotometry cannot distinguish between intact and degraded nucleic acids, nor can it detect specific contaminants that absorb at 260 nm (e.g., some buffers and salts). It also requires relatively high concentrations (>10 ng/µL) for accurate measurement.

Gel electrophoresis is semi-quantitative and requires relatively large amounts of sample (50–200 ng). It cannot detect low levels of degradation that may still affect PCR efficiency. Ethidium bromide staining is less sensitive than SYBR dyes.

Microfluidic electrophoresis requires specialized equipment and consumables that may not be available in all laboratories. RIN values can be affected by sample storage conditions and may not perfectly predict functional integrity for all RNA types (e.g., microRNA, degraded clinical samples).

Fluorometry provides accurate quantification but does not assess integrity. It requires specific dyes and instruments for DNA versus RNA quantification.

Sample-Specific Limitations

FFPE samples are typically degraded regardless of extraction quality. Standard integrity metrics (RIN, gel electrophoresis) may be misleading for these samples. DV200 is a more appropriate metric.

Environmental samples often contain co-extracted inhibitors (humic acids, polysaccharides) that may not be detected by standard quality metrics. Additional purification steps or inhibitor-tolerant polymerases may be required.

Low-biomass samples may not yield sufficient nucleic acid for comprehensive quality assessment. In such cases, prioritize fluorometric quantification and use the most sensitive integrity assessment available.

Interpretation Caveats

Template quality metrics are predictive but not definitive. A sample with acceptable quality metrics may still fail to amplify due to sequence-specific issues (e.g., secondary structure, GC content) or residual inhibitors. Conversely, a sample with marginal quality metrics may produce acceptable results for short amplicons or with optimized PCR conditions. Always validate template quality with functional assays (e.g., amplification of a reference gene) before proceeding with experimental samples.

Documentation and Reporting

Comprehensive documentation of template quality is essential for reproducibility and data interpretation. The MIQE guidelines recommend reporting the following information for qPCR studies [1]:

• RNA integrity assessment method and instrument
• RIN or RQI values for each sample
• A260/A280 and A260/A230 ratios
• Quantification method (spectrophotometry, fluorometry)
• Storage conditions and freeze-thaw history
• Any purification steps performed after initial extraction

For laboratory records, maintain a template quality log that includes:

• Sample identifier and source
• Extraction date and method
• Quality metrics (concentration, purity ratios, integrity scores)
• Gel or electropherogram images
• Acceptance/rejection decision and rationale
• Date of quality assessment and operator name

Biosafety Considerations

Template quality control procedures for PCR and qPCR typically involve BSL-1 materials and practices. The following biosafety considerations apply:

General Precautions

• Treat all biological samples as potentially infectious until characterized
• Use appropriate personal protective equipment (lab coat, gloves, eye protection)
• Perform all work in a designated laboratory area
• Decontaminate work surfaces before and after procedures with 10% bleach or 70% ethanol

Nucleic Acid Handling

• Use nuclease-free water and certified RNase/DNase-free consumables
• Change gloves frequently when handling RNA samples to prevent RNase contamination
• Store nucleic acids in clearly labeled, sealed tubes
• Dispose of contaminated materials according to institutional biosafety guidelines

Equipment Decontamination

• Clean spectrophotometer pedestals between samples with lint-free wipes
• Decontaminate gel electrophoresis equipment after use
• Follow manufacturer recommendations for microfluidic instrument maintenance

Regulatory Framework

The CDC and NIH provide authoritative guidance for biosafety practices in microbiological and biomedical laboratories [3]. For work involving recombinant or synthetic nucleic acids, consult the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [4]. These guidelines establish the institutional and biosafety framework for research involving nucleic acid amplification and manipulation.

Frequently Asked Questions

1. Can I use degraded DNA for PCR if my amplicon is very short?

Yes, degraded DNA can often amplify short targets (<300 bp) successfully. However, quantification will be unreliable because the number of amplifiable copies depends on the extent of degradation, which varies between samples. For qualitative PCR (presence/absence), degraded DNA may be acceptable if the target region remains intact. For quantitative applications, degraded DNA should be avoided or used only with careful validation and normalization.

2. Why does my RNA sample have a good RIN value but fail to amplify in RT-qPCR?

A good RIN value indicates that ribosomal RNA is intact, but it does not guarantee that messenger RNA (mRNA) is intact or that reverse transcription will be efficient. Possible causes include: residual inhibitors that block reverse transcriptase, genomic DNA contamination that competes for primers, or sequence-specific issues such as secondary structure in the target region. Perform an inhibitor spike-in test and a no-reverse-transcriptase control to distinguish these possibilities.

3. How should I store nucleic acid templates to maintain integrity?

DNA templates should be stored at -20°C in TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) to inhibit nucleases. RNA templates should be stored at -80°C in nuclease-free water or RNA storage buffer. Both should be aliquoted to avoid repeated freeze-thaw cycles. For long-term storage, consider ethanol precipitation or lyophilization. Avoid storing diluted templates for extended periods, as dilute nucleic acids are more susceptible to degradation.

4. What is the minimum amount of template I need for quality assessment?

For spectrophotometry, you need approximately 1–2 µL of sample at concentrations above 10 ng/µL. For gel electrophoresis, 50–200 ng of nucleic acid is typically required. For microfluidic electrophoresis, 1 µL of sample at 10–100 ng/µL is usually sufficient. For fluorometry, 1–10 µL of sample is needed depending on the assay. If sample quantity is limited, prioritize fluorometric quantification and use the most sensitive integrity assessment available.

References and Further Reading

1. Drude N, Baselly C, Gazda MA, et al. Reporting quality of quantitative polymerase chain reaction (qPCR) methods in scientific publications. PubMed. 2026. Link — Systematic evaluation of qPCR reporting practices, highlighting deficiencies in RNA integrity documentation.

2. Achs A, Sedlackova T, Predajna L, et al. Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no excessive DNA impurities. PubMed. 2025. Link — Demonstrates rigorous application of qPCR and orthogonal methods for nucleic acid quality assessment.

3. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services. 2020. Link — Authoritative principles for risk assessment and containment in microbiological laboratories.

4. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Link — Institutional framework for recombinant nucleic acid research.

5. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. Link — Searchable collection of authoritative biomedical methods references.

Related Articles

• No Template Control (NTC) in qPCR: Setup, Interpretation, and Troubleshooting
• Contamination Control in PCR and qPCR: Sources, Prevention, and Decontamination
• Controls in qPCR: No Template Control, No Reverse Transcriptase Control, and Positive Control
• Understanding No Template Control (NTC) Amplification in qPCR: Causes and Solutions
• Negative Controls in PCR and qPCR: Why They Matter and How to Set Them Up
• Reagent Control in PCR: Validating Water, Buffers, and Enzymes